S&P 500   3,855.05 (-1.79%)
DOW   31,579.41 (-1.20%)
QQQ   316.84 (-2.25%)
AAPL   123.01 (-1.87%)
MSFT   232.10 (-1.04%)
FB   257.92 (-2.42%)
GOOGL   2,039.36 (-2.13%)
AMZN   3,102.09 (-1.82%)
TSLA   702.18 (-5.37%)
NVDA   539.13 (-7.04%)
BABA   244.59 (-2.30%)
CGC   33.85 (-4.92%)
GE   12.91 (-1.60%)
MU   90.06 (-2.66%)
NIO   48.27 (-6.92%)
AMD   83.65 (-3.78%)
T   28.75 (-2.14%)
F   11.97 (-2.44%)
ACB   11.18 (-3.95%)
DIS   194.41 (-1.57%)
BA   221.11 (-3.59%)
NFLX   541.93 (-2.07%)
BAC   36.37 (-0.03%)
S&P 500   3,855.05 (-1.79%)
DOW   31,579.41 (-1.20%)
QQQ   316.84 (-2.25%)
AAPL   123.01 (-1.87%)
MSFT   232.10 (-1.04%)
FB   257.92 (-2.42%)
GOOGL   2,039.36 (-2.13%)
AMZN   3,102.09 (-1.82%)
TSLA   702.18 (-5.37%)
NVDA   539.13 (-7.04%)
BABA   244.59 (-2.30%)
CGC   33.85 (-4.92%)
GE   12.91 (-1.60%)
MU   90.06 (-2.66%)
NIO   48.27 (-6.92%)
AMD   83.65 (-3.78%)
T   28.75 (-2.14%)
F   11.97 (-2.44%)
ACB   11.18 (-3.95%)
DIS   194.41 (-1.57%)
BA   221.11 (-3.59%)
NFLX   541.93 (-2.07%)
BAC   36.37 (-0.03%)
S&P 500   3,855.05 (-1.79%)
DOW   31,579.41 (-1.20%)
QQQ   316.84 (-2.25%)
AAPL   123.01 (-1.87%)
MSFT   232.10 (-1.04%)
FB   257.92 (-2.42%)
GOOGL   2,039.36 (-2.13%)
AMZN   3,102.09 (-1.82%)
TSLA   702.18 (-5.37%)
NVDA   539.13 (-7.04%)
BABA   244.59 (-2.30%)
CGC   33.85 (-4.92%)
GE   12.91 (-1.60%)
MU   90.06 (-2.66%)
NIO   48.27 (-6.92%)
AMD   83.65 (-3.78%)
T   28.75 (-2.14%)
F   11.97 (-2.44%)
ACB   11.18 (-3.95%)
DIS   194.41 (-1.57%)
BA   221.11 (-3.59%)
NFLX   541.93 (-2.07%)
BAC   36.37 (-0.03%)
S&P 500   3,855.05 (-1.79%)
DOW   31,579.41 (-1.20%)
QQQ   316.84 (-2.25%)
AAPL   123.01 (-1.87%)
MSFT   232.10 (-1.04%)
FB   257.92 (-2.42%)
GOOGL   2,039.36 (-2.13%)
AMZN   3,102.09 (-1.82%)
TSLA   702.18 (-5.37%)
NVDA   539.13 (-7.04%)
BABA   244.59 (-2.30%)
CGC   33.85 (-4.92%)
GE   12.91 (-1.60%)
MU   90.06 (-2.66%)
NIO   48.27 (-6.92%)
AMD   83.65 (-3.78%)
T   28.75 (-2.14%)
F   11.97 (-2.44%)
ACB   11.18 (-3.95%)
DIS   194.41 (-1.57%)
BA   221.11 (-3.59%)
NFLX   541.93 (-2.07%)
BAC   36.37 (-0.03%)
Log in
NASDAQ:TPTX

Turning Point Therapeutics Earnings Date, Estimates & History

$115.91
-2.19 (-1.85 %)
(As of 02/25/2021 02:27 PM ET)
Add
Compare
Today's Range
$112.78
Now: $115.91
$119.01
50-Day Range
$116.77
MA: $129.27
$140.01
52-Week Range
$31.30
Now: $115.91
$141.30
Volume8,313 shs
Average Volume259,731 shs
Market Capitalization$5.58 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.23

Earnings

Turning Point Therapeutics has confirmed that its next quarterly earnings report will be published on Monday, March 1st, 2021. Turning Point Therapeutics will be holding an earnings conference call on Monday, March 1st. Interested parties can register for or listen to the call using this link.

Turning Point Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Turning Point Therapeutics (NASDAQ:TPTX) Earnings Estimates

2021 EPS Consensus Estimate: ($4.02)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20211($0.52)($0.52)($0.52)
Q2 20211($1.04)($1.04)($1.04)
Q3 20211($1.16)($1.16)($1.16)
Q4 20211($1.30)($1.30)($1.30)
Q1 20221($3.00)($3.00)($3.00)
Q2 20221($2.00)($2.00)($2.00)

Turning Point Therapeutics (NASDAQ TPTX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/1/2021
(Confirmed)
 ($0.94)    Register (After Market Closes)
11/12/20209/30/2020($0.79)($0.42)($0.09)$25.00 million$25.00 millionListen
8/10/20206/30/2020($0.89)($0.82)($0.82)N/A
5/12/20203/31/2020($0.66)($1.69)($1.69)Transcript
3/16/202012/31/2019($0.67)($0.58)($0.58)Listen
11/4/2019Q3($0.59)($0.63)($0.63)Transcript
8/6/2019Q2 2019($0.65)($0.70)($0.70)N/A
5/31/2019Q1 2019($3.97)($3.97)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.